The effects of siRNA-mediated knockdown of AP-1 on pulmonary arterial and right ventricular dysfunction associated with cardiac and pulmonary fibrosis in cardiopulmonary disease
Event: Frontiers in CardioVascular Biomedicine 2024
Topic: Vascular Diseases: Fibrosis
Session: Poster session 2
